Jeroen Rovers was most recently Chief Medical Officer at Ceronco Biosciences. Prior to that he was VP Medical Affairs at Kiadis Pharma and has remained a consultant to the Company until his re-appointment on September 1, 2014.
Kiadis Pharma appoints Jeroen Rovers as its Chief Medical Officer
Jeroen Rovers was most recently Chief Medical Officer at Ceronco Biosciences. Prior to that he was VP Medical Affairs at Kiadis Pharma and has remained a consultant to the Company until his re-appointment on September 1, 2014.
Tags
Related posts
- Trial reveals mechanisms that contribute to impact of malnutrition and HIV infection
- Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn
- New NIHR HRC launched for cardiovascular and respiratory medicine
- Study links dementia antipsychotics to higher risks of serious health outcomes
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
